Softcare (HKSE:02698) Research & Development: HK$9 Mil (TTM As of Dec. 2025)


HKSE:02698 Softcare Ltd HKSE:02698
23 GF Score
Price HK$24.46
! 2 Warning Signs
View Full Analysis

What is Softcare Research & Development?

Softcare HKSE:02698 -5.92% 23 Research & Development is HK$9 Mil as of Dec. 2025. GuruFocus rates HKSE:02698 with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Softcare's Research & Development for the six months ended in Dec. 2025 was HK$9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$9 Mil.

Softcare  (HKSE:02698) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Softcare Research & Development Related Terms

Softcare Research & Development Historical Data

* Premium members only.

The historical data trend for Softcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Softcare Research & Development Chart

Softcare Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
1.22 2.66 4.13 9.15

Softcare Semi-Annual Data
Dec22 Dec23 Dec24 Dec25
Research & Development 1.22 2.66 4.13 9.15
HKSE:02698
23GF Score
Softcare Ltd HKSE:02698
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Softcare Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$9 Mil mean?
Softcare (HKSE:02698) has a Research & Development of HK$9 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Softcare and its competitors.
Is Softcare's Research & Development too high?
Softcare's current Research & Development is HK$9 Mil. Overall, Softcare has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Softcare's Research & Development compare to PG and CL?
Softcare's Research & Development of HK$9 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Softcare and its competitors. Softcare's current Research & Development is HK$9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Softcare stock overvalued right now?
Softcare (HKSE:02698) has a current Research & Development of HK$9 Mil. The current Research & Development is HK$9 Mil. Softcare's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Softcare (HKSE:02698), the current Research & Development is HK$9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Softcare Business Description

Address 5 West A, Second Floor, 5WA 219, Dubai Airport Freezone, Dubai, ARE
Softcare Ltd is a hygiene product corporation principally engaged in the development, manufacturing and sales of baby and feminine hygiene products, including baby diapers, baby pants, sanitary pads and wet wipes. Geographically the company operates in Africa, Latin America and Central Asia. It offers a variety of baby and feminine hygiene products under brands like Softcare, as well as Veesper, Maya, Cuettie and Clincleer. The company generates the majority of its revenue from the sales of hygiene products in Africa.
23GF Score

Get the complete analysis for HKSE:02698

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$24.46
Price